Chemed (CHE) Capital Expenditures (2009 - 2026)

Chemed has reported Capital Expenditures for 18 years, with the latest figure at $17.1 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 28.89% year-over-year to $17.1 million; the trailing twelve-month figure through Mar 2026 stood at $66.6 million (up 31.56% YoY), and the FY2025 full-year result was $62.8 million, up 26.78% from the prior year.
• Capital Expenditures for Q1 2026 stood at $17.1 million, up from $16.3 million in the prior quarter.
• The five-year high for Capital Expenditures was $18.3 million in Q4 2022, with the low at $11.1 million in Q2 2024.
• Average Capital Expenditures over 5 years is $14.3 million, with a median of $13.5 million recorded in 2022.
• Year-over-year, Capital Expenditures plunged 35.49% in 2023 and jumped 42.9% in 2025.
• Tracing CHE's Capital Expenditures over 5 years: stood at $18.3 million in 2022, then sank by 35.49% to $11.8 million in 2023, then climbed by 8.34% to $12.8 million in 2024, then gained by 28.11% to $16.3 million in 2025, then climbed by 4.7% to $17.1 million in 2026.
• The last three Capital Expenditures figures came in at $17.1 million (Q1 2026), $16.3 million (Q4 2025), and $17.4 million (Q3 2025), per Business Quant data.

Peer Comparison